Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification
Reexamination Certificate
2006-05-23
2006-05-23
Guzo, David (Department: 1636)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
C435S455000, C435S468000, C514S04400A
Reexamination Certificate
active
07049142
ABSTRACT:
A process and compound wherein nucleic acids can be modified with a host of molecules and maintain their ability to be expressed. A modifying chemical attachment of polyions to polynucleotides can be used to facilitate the change of tertiary structure of the nucleic acid and in some cases condensation of nucleic acids into smaller, charged particles useful in delivering the nucleic acid to a cell.
REFERENCES:
patent: 4950744 (1990-08-01), Dattagupta
patent: WO 99/13719 (1999-03-01), None
Ireland et al. DNA-mediated gene transfer as an indicator of DNA damage and its repair by recipient cells. FEBS Lett. Feb. 9, 1987;212(1):173-6.
Neves et al. Novel method for covalent fluorescent labeling of plasmid DNA that maintains structural integrity of the plasmid. Bioconjug Chem. Jan.-Feb. 2000;11(1):51-5.
Zelphati et al. Gene chemistry: functionally and conformationally intact fluorescent plasmid DNA. Hum Gene Ther. Jan. 1, 1999;10(1):15-24.
Emanueli et al. Angiogenesis gene therapy to rescue ischaemic tissues: achievements and future directions. Br J Pharmacol. Aug. 2001;133(7):951-8.
Schwaab et al. Gene therapy of hemophilia. Semin Thromb Hemost. Aug. 2001;27(4):417-24.
Rissanen et al. Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb—on the way to the clinic. Eur J Clin Invest. Aug. 2001;31(8):651-66.
Ross et al. Gene therapy in the United States: a five-year status report. Hum Gene Ther. Sep. 10, 1996;7(14):1781-90.
Marshall Gene therapy's growing pains. Science. Aug. 25, 1995;269(5227):1050, 1052-5.
Verma et al. Gene therapy—promises, problems and prospects. Nature. Sep. 18, 1997;389(6648):239-42.
Pierce Chemical Technical Library “Other biotinylation reagents: Immonopure photoactivatable biotin” available at http://www.piercenet.com.
Eck et al. Chapter 5: Gene-Based Therapy in “Goodman & Gilman's The Pharmaceutical Basis of Therapeutics”, Ninth Edition, McGraw-Hill, New York.
Orkin et al. Dec. 7, 1995, “Report and recommendations of the panel to assess teh NIH investment in research on gene therapy” available through the National Institutes of Health and online at http://www.nih.gov
ews/panelrep/.
Slattum et al. Efficient in vitro and in vivo expression of covalently modified plasmid DNA. Mol Ther. Aug. 2003;8(2):255-63.
Chang, Alan G., et al., “Gene Therapy: Applications to the Treatment of Gastrointestinal and Liver Diseases.”Gastroenterology; 1994; 106; pp. 1076-1084.
Cheng, Sheue-yann, et al., “A Versatile Method for the Coupling of Protein to DNA: Synthesis of a-Macroglobulin-DNA Conjugates.”Nucleic Acids Research; 1983; vol. 11, No. 3; pp. 659-669.
Chowdhury, Namita Roy, et al., “Fate of DNA Targeted to the Liver by Asialoglycoprotein Receptor-mediated Endocytosisin Vivo.” The Journal of Biological Chemistry; May 25, 1993; vol. 236, No. 15, pp. 11265-11271.
Leahy, Patrick, et al., “Novel Biotinylated Plasmic Expression Vectors Retain Biological Function and Can Bind Streptavidin.”Bioconjugate Chem; 1996; 7; pp. 545-551.
Perales, Jose Carlos, et al., “Gene TransferIn Vivo: Sustained Expression and Regulation of Genes Introduced Into the Liver by Receptor-Targeted Uptake.”Proc. Natl. Acad. Sci. USA, Medical Sciences; Apr. 1994; vol. 91; pp. 4086-4090.
Sperling, Joseph, et al., “Photochemical Cross-Linking of Histones to DNA in Nuclosomes.”Nucleic Acids Research; Aug. 1978; vol. 5, No. 8, pp. 2755-2773.
Vanin, E.F., et al., “Azicophenylglyoxal: A Heterobifunctional Photosensitive Reagent.”FEBS Letters; Feb. 1981; vol. 124, No. 1; pp. 89-92.
Zhang, Guofeng, et al., “Efficient Expression of Naked DNA Intraarterially to Limb Muscles of Nonhuman Primates.”Human Gene Therapy; Mar. 1, 2001; 12:000-000; pp. 427-438.
Arima H et al. “Enhancement of gene expression by the polyamidoamine dendrimer conjugates with α-, β- and γ- cyclodextrins,” Bioconjugate Chem; 2001 vol. 12 pp. 476-484.
Kihara F et al. “Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with α-cyclodextrin,” Bioconjugate Chem; 2002 vol. 13.pp. 1211-1219.
Klugherz BD et al. “Gene delivery from a DNA controlled-release stent in porcine coronary arteries,” Nat Biotechnol; 2000 vol. 18 No. 11 pp. 1181-1184.
Rebuffat A et al. “Selective enhancement of gene transfer by steroid-mediated gene delivery,” Nature Biotechnology; 2001 vol. 19 pp. 1155-1161.
Salman et al. “Kinetics and mechanism of DNA uptake into the cell nucleus,” Proc Natl Acad Sci USA; 2001 vol. 98 No. 13 pp. 7247-7252.
Budker Vladimir G.
Hagstrom James E.
Slattum Paul M.
Wolff Jon A.
Ekena Kirk
Guzo David
Johnson Mark K.
Mirus Corporation
Sullivan Daniel M.
LandOfFree
Gene expression with covalently modified polynucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene expression with covalently modified polynucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene expression with covalently modified polynucleotides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3624889